Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC)
Year: 2019
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: S. Singh, S. Nuyts, R. Doline, S. Satti, M. Schwartz, S. Thatcher, Y. Chen, S. Katz, M. Garg, J. Wagemans, P. Specenier, C. Wittekindt, L. Lee, J. Reifler, S. Sonis, M. Emanuel, F. Cilli, A. Joslyn, J. Wade
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2978994146